CELLECTIVE BIOTHERAPY
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency. The biotechnology company focuses on the research and development of B cell-based cellular therapies for immunomodulation, immunodeficiency, and autoimmunity. It researches treatment for cancers, diabetes, asthma, and congenital and acquired immunodeficiency, and vaccine development.
CELLECTIVE BIOTHERAPY
Industry:
Biotechnology Health Care Information Technology Medical Medical Device
Founded:
2015-04-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.cellectivebiotherapy.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin ReCAPTCHA
Similar Organizations
Proteona
Proteona develops a genomic and proteomic analysis platform designed for immuno-oncology and immune profiling applications.
Current Employees Featured
Founder
Investors List
Eshelman Ventures
Eshelman Ventures investment in Angel Round - Cellective BioTherapy
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Cellective BioTherapy
Official Site Inspections
http://www.cellectivebiotherapy.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cellective BioTherapy"
Cellective BioTherapy - Crunchbase Company Profile & Funding
Contact Email [email protected] Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency. …See details»
Cellective BioTherapy - PitchBook
Cellective BioTherapy General Information Description. Developer of a biotechnology platform designed to enhance or inhibit immune responses. The company's platform provides the ability …See details»
Cellective BioTherapy, Inc — Duke OTC
B cell-based cellular therapies for immunomodulation, immunodeficiency and autoimmunity CBT is an early-stage biotech spinout with a proprietary pipeline and technology platform focused on unique aspects of B cell biology that are …See details»
Cellective BioTherapy Company Profile | Management and
Company Name. Cellective BioTherapy. Main Industry. Business Services, Research & Development. Website. www.cellectivebiotherapy.comSee details»
Cellective BioTherapy - Products, Competitors, Financials, …
Cellectivebiotherapy.com. Overview & Products; Financials; People; Founded Year 2015. Stage Seed | Alive. Total Raised $2.5M. Last Raised $2.5M | 10 yrs ago. About Cellective …See details»
Cellective BioTherapy - Craft
Cellective BioTherapy is a company that develops cell-based immunotherapies. It focuses on cellular and monoclonal antibody-based platforms for treating cancers, infectious diseases, …See details»
Cellective BioTherapy - Overview, News & Similar companies
Who is Cellective BioTherapy. Cellective BioTherapy, Inc. is focused on developing novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and …See details»
Cellective BioTherapy - The Org
Cellective BioTherapy, Inc. (CBT) is a biotechnology company founded in 2015 that is developing antibody and cell-based approaches to harnessing regulatory B (B10) cells for both augmenting a patient's immunity against tumors and for …See details»
Cellective BioTherapy - CoBee Company Profile & Funding Rounds
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency. The biotechnology company focuses on the …See details»
Cellective BioTherapy - VentureRadar
Website: http://cellectivebiotherapy.com. Develops innovative B10 cell-based immunotherapies for cancer, autoimmunity, and immunodeficiency treatment, with ...See details»
Cellective BioTherapy, Inc. - Research Triangle Park
700 Park Offices Drive, Suite 007 Research Triangle Park, NC 27709See details»
Cellective Biotherapy, Inc. Company Profile - Powrbot list of …
Cellectivebiotherapy.com : Snippet Country united states Founded 2015.0 Website cellectivebiotherapy.com ...See details»
Cellective BioTherapy Corporate Headquarters, Office Locations …
Cellective BioTherapy is headquartered in Durham, 6 Davis Dr, United States, and has 1 office location.See details»
Cellective Therapeutics - Crunchbase Company Profile & Funding
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with …See details»
Cellective BioTherapy CEO and Key Executive Team | Craft.co
Cellective BioTherapy's Chairman is Fred Eshelman. Other executives include Thomas F. Tedder, Founder, Chief Executive Officer & Director; Robert Bonczek, Chief Financial Officer & …See details»
Dr. Thomas F. Tedder - CEO, Founder - Crunchbase
Dr. Thomas F. Tedder - CEO, Founder @ Cellective BioTherapySee details»
Cellective BioTherapy Careers, Perks + Culture - Built In
Learn more about Cellective BioTherapy. Find jobs, explore benefits, and research company culture at Built In.See details»
Cellective BioTherapy - VentureRadar
Similar Companies: Nascent Biotech USA n/a Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of …See details»
Cellective BioTherapy CEO, Founder, Key Executive Team, Board of ...
Explore {Cellective BioTherapy's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Cellective AI
Cellective AI is pioneering next-generation cancer treatment by training immune cells with AI-driven technology. Discover how we are transforming immunotherapy without genetic …See details»